Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)

India · Delayed Price · Currency is INR

108.15

-0.89 (-0.82%)

Nov 11, 2026, 2:38 PM IST

Market Cap	3.08B +10.9%
Revenue (ttm)	4.15B -7.7%
Net Income	36.20M -12.9%
EPS	1.27 -14.0%
Shares Out	n/a
PE Ratio	85.16
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	144,947
Open	109.04
Previous Close	109.04
Day's Range	107.82 - 110.00
52-Week Range	50.31 - 114.80
Beta	1.24
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2026

About NSE:AAREYDRUGS

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1990

Employees 132

Stock Exchange National Stock Exchange of India

Ticker Symbol AAREYDRUGS

Full Company Profile

Financial Performance

In fiscal year 2026, NSE:AAREYDRUGS's revenue was 4.72 billion, a decrease of -0.35% compared to the previous year's 4.74 billion. Earnings were 39.68 million, a decrease of -1.40%.

Financial Statements